JNJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Johnson & Johnson's research and development for the three months ended in Dec. 2013 was $2,411 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2013 was $8,183 Mil.
This is the expense the company spent on research and development.
Johnson & Johnson Research & Development for the trailing twelve months (TTM) ended in Dec. 2013 was 1784 (Mar. 2013 ) + 1946 (Jun. 2013 ) + 2042 (Sep. 2013 ) + 2411 (Dec. 2013 ) = $8,183 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Johnson & Johnson Annual Data
|Research & Development||5,344||6,462||7,125||7,680||7,577||6,986||6,844||7,548||7,665||8,183|
Johnson & Johnson Quarterly Data
|Research & Development||1,773||2,155||1,645||1,766||1,923||2,331||1,784||1,946||2,042||2,411|